Skip to Main Content

Author Details

Ben van Hout
University of Sheffield
1993
158
47
PMIDPaper TitleJournal TitlePublished Year
33063111Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden.Eur Heart J Qual Care Clin Outcomes2022
36060298The Online Elicitation of Personal Utility Functions (OPUF) tool: a new method for valuing health states.Wellcome Open Res2022
34997918Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.Adv Ther2022
34796464An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.Adv Ther2022
34452708Mapping EQ-5D-3L to EQ-5D-5L.Value Health2021
33526502Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review.BMJ Open2021
32389231The EQ-5D-5L Value Set for England: Response to the "Quality Assurance".Value Health2020
33317069Mortality Prediction of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation.J Clin Med2020
33062927Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis.TH Open2020
30661630Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.Value Health2019
31840534Deep Vein Thrombosis in Europe-Health-Related Quality of Life and Mortality.Clin Appl Thromb Hemost2019
32699987Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting.Oncol Ther2019
30030647A new method for valuing health: directly eliciting personal utility functions.Eur J Health Econ2019
30949836Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries.Qual Life Res2019
31166576Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease.JAMA Cardiol2019
30607785Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis.Qual Life Res2019
28833854New methods for modelling EQ-5D-5L value sets: An application to English data.Health Econ2018
30218272The impact of co-morbidity on the disease burden of VTE.J Thromb Thrombolysis2018
30034645Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK.J Mark Access Health Policy2018
30199784Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work.Thromb Res2018
30196194Deep-vein thrombosis in Europe - Burden of illness in relationship to healthcare resource utilization and return to work.Thromb Res2018
29476363Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.Pharmacoeconomics2018
29774632An exploration of the non-iterative time trade-off method to value health states.Health Econ2018
29679315Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.Pharmacoeconomics2018
28833869Valuing health-related quality of life: An EQ-5D-5L value set for England.Health Econ2018
28535105The Importance of Economic Perspective and Quantitative Approaches in Oncology Value Frameworks of Drug Selection and Shared Decision Making.J Manag Care Spec Pharm2017
28366593Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.Clin Ther2017
29052162International Regulations and Recommendations for Utility Data for Health Technology Assessment.Pharmacoeconomics2017
29052161Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care.Pharmacoeconomics2017
28832867Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.JAMA Cardiol2017
27092712Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States.Clin Cardiol2016
27429719Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.J Mark Access Health Policy2016
25398621A comparison of methods for converting DCE values onto the full health-dead QALY scale.Med Decis Making2015
26099515Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden.Cardiol Ther2015
26091591The Continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction.Value Health2015
26059521Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease.BMJ Open2015
24399818Assessing uncertainties surrounding combined endpoints for use in economic models.Med Decis Making2014
29702801Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.Value Health Reg Issues2014
27201835Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events.Value Health2014
25000846Predicting preference-based utility values using partial proportional odds models.BMC Res Notes2014
24969006A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.Value Health2014
25100229Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values.Med Care2014
22715069A comparison of alternative variants of the lead and lag time TTO.Health Econ2013
24286567Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment.Acta Orthop2013
21542113Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.Catheter Cardiovasc Interv2012
22765255Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.Patient2012
22867780Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.Value Health2012
22433767Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy.Value Health2012
21880046Cost-effectiveness of additional blood screening tests in the Netherlands.Transfusion2012
20726957Survival after transfusion in the Netherlands.Vox Sang2011
  • 1 - 50 of 158

Recommended Authors

Spyros Kolovos
University of Oxford
Career Start Year 2016
Number of shared co-authors 0
Seamus Kent
National Institute for Health and Care Excellence
Career Start Year 2013
Number of shared co-authors 0
Thomas Butt
UCL Institute of Ophthalmology, University College London
Career Start Year 2013
Number of shared co-authors 0
Bart S Ferket
Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 1
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 0
Jeff Round
Institute of Health Economics, University of Alberta
Career Start Year 2010
Number of shared co-authors 0
Mike Paulden
School of Public Health, University of Alberta
Career Start Year 2009
Number of shared co-authors 0
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 1
James Buchanan
Health Economics Research Centre, University of Oxford
Career Start Year 2007
Number of shared co-authors 0
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Maarten J IJzerman
Technical Medical Centre, University of Twente
Career Start Year 1997
Number of shared co-authors 0
Sarah Wordsworth
Health Economics Research Centre, University of Oxford
Career Start Year 1997
Number of shared co-authors 0
Manuel Ridao
Instituto Aragones de Ciencias de la Salud (IIS Aragon)
Career Start Year 1997
Number of shared co-authors 0
Christopher McCabe
Queens University Belfast
Career Start Year 1996
Number of shared co-authors 0
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 0
Mireille Goetghebeur
School of Public Health, Universite de Montreal 1
Career Start Year 1995
Number of shared co-authors 0
Andrew Walker
University of California San Diego
Career Start Year 1995
Number of shared co-authors 0
George Tomlinson
University Health Network
Career Start Year 1994
Number of shared co-authors 0
David L Veenstra
University of Washington
Career Start Year 1992
Number of shared co-authors 1
Ewout W Steyerberg
Leiden University Medical Center
Career Start Year 1992
Number of shared co-authors 5
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 4
Jesse A Berlin
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 0
Joel Tsevat
Dell Medical School, University of Texas at Austin
Career Start Year 1987
Number of shared co-authors 1
John B Wong
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 1
Frank A Sonnenberg
Robert Wood Johnson Medical School, The State University of New Jersey
Career Start Year 1986
Number of shared co-authors 0
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 0
Myriam G M Hunink
13Center for Health Decision Sciences, Harvard T.H. Chan School of Public Health
Career Start Year 1984
Number of shared co-authors 1
Theodore G Ganiats
university of california san diego
Career Start Year 1983
Number of shared co-authors 2
Stan N Finkelstein
University of Toronto
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 5
Albert Hofman
Harvard T.H. Chan School of Public Health
Co-authored papers 5
Diederick E Grobbee
Co-authored papers 4
Huibert A P Pols
Co-authored papers 4
G Clermont
University of Pittsburgh
Co-authored papers 2
Derek C Angus
University of Pittsburgh Medical Center
Co-authored papers 2
David J Cohen
Clinical Trials Center, Cardiovascular Research Foundation
Co-authored papers 2
Jean-Louis Vincent
Erasme Hospital, Universite Libre de Bruxelles
Co-authored papers 2
Walter T Linde-Zwirble
The CRISMA Laboratory (Clinical Research, University of Pittsburgh
Co-authored papers 2
Bruce R Basson
Lilly Research Laboratories
Co-authored papers 1
Pierre-Fran??ois Laterre
Centre Hospitalier Regional Mons-Hainaut
Co-authored papers 1
Karel G M Moons
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Trecht University
Co-authored papers 1
Vladimir Kaplan
Hospital Muri
Co-authored papers 1
Jacqueline C M Witteman
Co-authored papers 1
Jako S Burgers
Universiteit Maastricht
Co-authored papers 1
Alexander A Vinks
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
Eugene Wesley Ely
Vanderbilt University Medical Center
Co-authored papers 1
Daniel E Ball
Lilly Research Laboratories
Co-authored papers 1
Gordon R Bernard
Vanderbilt University
Co-authored papers 1
Duane S Pinto
Beth Israel Deaconess Medical Center
Co-authored papers 1
Marc S Sabatine
Brigham and Women's Hospital
Co-authored papers 1
Rui Moreno
Faculdade de Ciencias da Saude, Universidade da Beira Interior
Co-authored papers 1
Brian M Feldman
Co-authored papers 1
Patrick M M Bossuyt
University of Amsterdam
Co-authored papers 1
Robert P Giugliano
Co-authored papers 1
Release 1.2